Genetic tests can also help find gene mutations which indicate if a patient is eligible for specific types of clinical trials. The Amplitude clinical trial is one such trial which is highlighted below. The Amplitude trial not only incorporates genetic testing, but also the PARP inhibitor Niraparib. Niraparib has received FDA approval for other types of cancers.
1 in 6 prostate cancers are caused by an inherited genetic mutation